Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Kennedy Jr., a prominent vaccine skeptic. With the new data ... The company so far appears to be the frontrunner in the race against Pfizer and Novavax to bring a combination shot to the market. While ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

The latest trading day saw Novavax (NVAX) settling at $6.36, representing a -2.15% change from its previous close.

Novavax is a leading pharmaceutical company dedicated to creating protein-based vaccines for diseases like COVID-19 and malaria. Learn more about their innovative vaccine development process and ...

The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has ...

The panel also voted to recommend Merck’s RSV antibody drug Enflonsia for newborns whose mothers didn’t receive prenatal ...

View the latest Novavax Inc. (NVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ.